219
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Stereotactic radiosurgery for cerebellopontine meningiomas: a systematic review and meta-analysis

, , ORCID Icon, , , , & show all
Pages 199-205 | Received 12 Sep 2020, Accepted 06 Apr 2022, Published online: 27 Apr 2022

References

  • Kim SH, Lee SH, Choi SK, Lim YJ, et al. Audiologic evaluation of vestibular schwannoma and other cerebellopontine angle tumors. Acta Otolaryngol 2016;136:149–53.
  • Moffat DA, Ballagh RH. Rare tumours of the cerebellopontine angle. Clin Oncol 1995;7:28–41.
  • Tekkök IH, Süzer T, Erbengi A. Non-acoustic tumors of the cerebellopontine angle. Neurosurg Rev 1992;15:117–23.
  • Goebel S, Mehdorn HM. A missing piece? Neuropsychiatric functioning in untreated patients with tumors within the cerebellopontine angle. J Neurooncol 2018;140:145–53.
  • Kankane V, Warade A, Misra B. Nonvestibular schwannoma tumors in the cerebellopontine angle: a single-surgeon experience. Asian J Neurosurg 2019;14:154–61.
  • Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg 1980;88:555–9.
  • Granick MS, Martuza RL, Parker SW, Ojemann RG, et al. Cerebellopontine angle meningiomas: clinical manifestations and diagnosis. Ann Otol Rhinol Laryngol 1985;94:34–8.
  • Nicolato A, Foroni R, Pellegrino M, Ferraresi P, et al. Gamma knife radiosurgery in meningiomas of the posterior fossa. Experience with 62 treated lesions. Minim Invasive Neurosurg 2001;44:211–7.
  • Pollock BE, Stafford SL, Link MJ, Brown PD, et al. Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery 2012;71:604–12.
  • El-Shehaby AMN, Reda WA, Abdel Karim KM, Nabeel AM, et al. Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas. J Neurosurg 2018;129:38–46.
  • Kim YH, Kim DG, Han JH, Chung HT, et al. Radiosurgery for para-IAC meningiomas: the effect of radiation dose to the cochlea on hearing outcome. Int J Radiat Oncol Biol Phys 2012;84:675–80.
  • Pollock BE, Link MJ, Foote RL, Stafford SL, et al. Radiosurgery as primary management for meningiomas extending into the internal auditory canal. Stereotact Funct Neurosurg 2004;82:98–103.
  • Ding D, Starke RM, Kano H, Nakaji P, et al. Gamma knife radiosurgery for cerebellopontine angle meningiomas: a multicenter study. Neurosurgery 2014;75:398–408.
  • Jahanbakhshi A, Azar M, Kazemi F, Jalessi M, et al. Gamma Knife stereotactic radiosurgery for cerebellopontine angle meningioma. Clin Neurol Neurosurg 2019;187:105557.
  • Carlstrom LP, Jacob JT, Graffeo CS, Perry A, et al. Impact of cochlear modiolus dose on hearing preservation following stereotactic radiosurgery for non-vestibular schwannoma neoplasms of the lateral skull base: a cohort study. J Neurosurg 2019;1–6.
  • Yang I, Sughrue ME, Han SJ, Fang S, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009;93:41–8.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
  • Lefebvre C, Manheimer E, Glanville J, 2011. Chapter 06: Searching for Studies. In: Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Policy Institute. London, England.
  • Di Carlo DT, Capo G, Fava A, Cagnazzo F, et al. Petroclival meningiomas: the risk of post-operative cranial nerve deficits among different surgical approaches-a systematic review and meta-analysis. Acta Neurochir (Wien) 2020;162:2135–43.
  • Akyoldaş G, Samancı Y, Yılmaz M, Şengöz M, Peker S. Long-term results of gamma knife radiosurgery for foramen magnum meningiomas. Neurosurg Rev 2021;44:2667–73.
  • Gendreau J, Surgical outcomes after stereotactic radiosurgery for cerebellopontine meningiomas: a systematic review and meta-analysis dataset. Harvard Dataverse.
  • Wells GA, Shea B, D O’Connell JP, et al. Newcastle-Ottawa quality assessment form for cohort studies. The Ottawa Hospital. Accessed at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed on April 13th, 2022.
  • Kim H-Y. Statistical notes for clinical researchers: risk difference, risk ratio, and odds ratio. Restor Dent Endod 2017;42:72–6.
  • Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics 2018;74:785–94.
  • Faramand A, Kano H, Niranjan A, Johnson SA, et al. Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas. J Neurooncol 2018;139:341–8.
  • Faramand A, Kano H, Niranjan A, Park KJ, et al. Tumor Control and Cranial Nerve Outcomes After Adjuvant Radiosurgery for Low-Grade Skull Base Meningiomas. World Neurosurg 2019;127:221–9.
  • Park SH, Kano H, Niranjan A, Flickinger JC, et al. Stereotactic radiosurgery for cerebellopontine angle meningiomas. J Neurosurg 2014;120:708–15.
  • Chang CS, Chuang CC, Wu MF, Liu WS, et al. Gamma Knife surgery for hemifacial spasm related to cerebellopontine angle tumors. J Neurosurg 2012;117:170–4.
  • Hasegawa T, Kida Y, Kato T, Iizuka H, et al. Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg 2013;118:557–65.
  • Kano H, Takahashi JA, Katsuki T, Araki N, et al. Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 2007;84:41–7.
  • Koga T, Shin M, Saito N. Treatment with high marginal dose is mandatory to achieve long-term control of skull base chordomas and chondrosarcomas by means of stereotactic radiosurgery. J Neurooncol 2010;98:233–8.
  • Mallory GW, Pollock BE, Foote RL, Carlson ML, et al. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery 2014;74:292–300.
  • Voss NF, Vrionis FD, Heilman CB, Robertson JH. Meningiomas of the cerebellopontine angle. Surg Neurol 2000;53:439–46.
  • Xu Z, Yen CP, Schlesinger D, Sheehan J. Outcomes of Gamma Knife surgery for craniopharyngiomas. J Neurooncol 2011;104:305–13.
  • Jumah F, Narayan V, Samara A, Quinoa TR, et al. Efficacy and safety of gamma knife radiosurgery for posterior cranial fossa meningioma: a systematic review. Neurosurg Rev 2020;43:1089–99.
  • El-Khatib M, Majdoub FE, Hoevels M, Kocher M, et al. Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas. Acta Neurochir (Wien) 2011;153:1761–7.
  • Acker G, Meinert F, Conti A, Kufeld M, et al. Image-Guided Robotic Radiosurgery for Treatment of Recurrent Grade II and III Meningiomas. A Single-Center Study. World Neurosurg 2019;131:96–107.
  • Chung LK, Ung N, Sheppard JP, Nguyen T, et al. Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma. J Neurol Surgery. J Neurol Surg B Skull Base 2018;79:335–42.
  • Patel KS, Ng E, Kaur T, Miao T, et al. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. J Neurooncol 2019;145:329–37.
  • Smith DR, Saadatmand HJ, Wu CC, Black PJ, et al. Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas. Neurosurg 2019;85:E1084–1094.
  • Van Linge A, Van Os R, Hoekstra N, Heijmen B, et al. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. Radiat Oncol 2018;13:253.
  • Baschnagel AM, Chen PY, Bojrab D, Pieper D, et al. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery. J Neurosurg 2013;118:571–8.
  • Kano H, Kondziolka D, Khan A, Flickinger JC, et al. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg 2009;111:863–73.
  • Massager N, Nissim O, Delbrouck C, Delpierre I, et al. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg 2007;107:733–9.
  • Senova S, Aggad M, Golmard JL, Hasboun D, et al. Predictors of trigeminal neuropathy after radiosurgery for vestibular schwannomas. Int J Radiat Oncol Biol Phys 2016;95:721–8.
  • Pollock BE, Link MJ, Branda ME, Storlie CB. Incidence and management of late adverse radiation effects after arteriovenous malformation radiosurgery. Neurosurgery 2017;81:928–34.
  • Kano H, Flickinger JC, Tonetti D, Hsu A, et al. Estimating the risks of adverse radiation effects after gamma knife radiosurgery for arteriovenous malformations. Stroke 2017;48:84–90.
  • Lu XY, Sun H, Xu JG, Li QY. Stereotactic radiosurgery of brainstem cavernous malformations: a systematic review and meta-analysis: a review. J Neurosurg 2014;120:982–7.
  • Nagy G, Grainger A, Hodgson TJ, Rowe JG, et al. Staged-volume radiosurgery of large arteriovenous malformations improves outcome by reducing the rate of adverse radiation effects. Neurosurgery 2017;80:180–92.
  • Stojadinovic S, Yan Y, Leiker A, Ahn C, et al. Considerations of target surface area and the risk of radiosurgical toxicity. PLoS One 2019;14:e0224047.
  • Symon L, Pell M, Singh L. Surgical management of posterior cranial fossa meningiomas. Br J Neurosurg 1993;7:599–609.
  • Hayhurst C, Monsalves E, Bernstein M, Gentili F, et al. Predicting nonauditory adverse radiation effects following radiosurgery for vestibular schwannoma: a volume and dosimetric analysis. Int J Radiat Oncol Biol Phys 2012;82:2041–6.
  • Tuleasca C, George M, Faouzi M, Schiappacasse L, et al. Acute clinical adverse radiation effects after Gamma Knife surgery for vestibular schwannomas. J Neurosurg 2016;125:73–82.
  • Kaprealian T, Raleigh DR, Sneed PK, Nabavizadeh N, et al. Parameters influencing local control of meningiomas treated with radiosurgery. J Neurooncol 2016;128:357–64.
  • Park CK, Jung NY, Chang WS, Jung HH, et al. Gamma knife radiosurgery for postoperative remnant meningioma: analysis of recurrence factors according to world health organization grade. World Neurosurg 2019;132:399–402.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.